Overview
Lin Su practices practicing medicine in Sar, China.
Their clinical expertise encompasses Hepatoblastoma, Lung Cancer, Liver Cancer, and Non-Small Cell Lung Cancer (NSCLC).
They are actively involved in clinical research, co-authoring 51 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lin Su
Is Lin Su a top-rated expert for Hepatoblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Lin Su is classified as an Experienced expert for Hepatoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lin Su participate in research or clinical trials?
Yes. Lin Su has published 51 articles and abstracts on conditions like Hepatoblastoma. You can view a list of Lin Su's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HepatoblastomaSu isExperienced. Learn about Hepatoblastoma.
- Liver CancerSu isExperienced. Learn about Liver Cancer.
- Lung CancerSu isExperienced. Learn about Lung Cancer.
- Mononeuritis MultiplexSu isExperienced. Learn about Mononeuritis Multiplex.
- Non-Small Cell Lung Cancer (NSCLC)